Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Covington
QuintilesIMS
UBS
Express Scripts
Johnson and Johnson
Argus Health
Merck
Julphar
Healthtrust

Generated: January 18, 2018

DrugPatentWatch Database Preview

Clonidine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for clonidine hydrochloride and what is the scope of clonidine hydrochloride freedom to operate?

Clonidine hydrochloride
is the generic ingredient in five branded drugs marketed by Exela Pharma Scs Llc, Fresenius Kabi Usa, Hikma Farmaceutica, Luitpold, Zydus Pharms Usa Inc, Mylan Institutional, Actavis Elizabeth, Anchen Pharms, Lupin Ltd, Concordia Pharms Inc, Boehringer Ingelheim, Alembic Pharms Ltd, Am Therap, Aurolife Pharma Llc, Chartwell Molecules, Duramed Pharms Barr, Frontida Biopharm, Impax Labs, Interpharm, Mylan, Par Pharm, Prinston Inc, Sun Pharm Inds Inc, Teva, Unichem, Warner Chilcott, Watson Labs, and Yung Shin Pharm, and is included in fifty-four NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-two drug master file entries for clonidine hydrochloride. Sixty-four suppliers are listed for this compound.
Pharmacology for clonidine hydrochloride

US Patents and Regulatory Information for clonidine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Unichem CLONIDINE HYDROCHLORIDE clonidine hydrochloride TABLET;ORAL 078895-003 Aug 26, 2009 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Alembic Pharms Ltd CLONIDINE HYDROCHLORIDE clonidine hydrochloride TABLET;ORAL 091368-003 Dec 6, 2011 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Boehringer Ingelheim CATAPRES clonidine hydrochloride TABLET;ORAL 017407-002 Approved Prior to Jan 1, 1982 AB RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Warner Chilcott CLONIDINE HYDROCHLORIDE clonidine hydrochloride TABLET;ORAL 072139-001 Jun 13, 1988 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Unichem CLONIDINE HYDROCHLORIDE clonidine hydrochloride TABLET;ORAL 078895-002 Aug 26, 2009 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Chartwell Molecules CLONIDINE HYDROCHLORIDE clonidine hydrochloride TABLET;ORAL 071785-001 Apr 5, 1988 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Duramed Pharms Barr CLONIDINE HYDROCHLORIDE clonidine hydrochloride TABLET;ORAL 071103-001 Aug 14, 1986 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Impax Labs CLONIDINE HYDROCHLORIDE clonidine hydrochloride TABLET;ORAL 078099-002 Aug 27, 2009 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Duramed Pharms Barr CLONIDINE HYDROCHLORIDE clonidine hydrochloride TABLET;ORAL 071101-001 Aug 14, 1986 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan CLONIDINE HYDROCHLORIDE clonidine hydrochloride TABLET;ORAL 070317-001 Jun 9, 1987 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for clonidine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Boehringer Ingelheim CATAPRES clonidine hydrochloride TABLET;ORAL 017407-001 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Concordia Pharms Inc JENLOGA clonidine hydrochloride TABLET, EXTENDED RELEASE;ORAL 022331-001 Sep 30, 2009 ➤ Subscribe ➤ Subscribe
Concordia Pharms Inc JENLOGA clonidine hydrochloride TABLET, EXTENDED RELEASE;ORAL 022331-002 May 25, 2010 ➤ Subscribe ➤ Subscribe
Boehringer Ingelheim CATAPRES clonidine hydrochloride TABLET;ORAL 017407-002 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Concordia Pharms Inc KAPVAY clonidine hydrochloride TABLET, EXTENDED RELEASE;ORAL 022331-004 Sep 28, 2010 ➤ Subscribe ➤ Subscribe
Concordia Pharms Inc KAPVAY clonidine hydrochloride TABLET, EXTENDED RELEASE;ORAL 022331-003 Sep 28, 2010 ➤ Subscribe ➤ Subscribe
Boehringer Ingelheim CATAPRES clonidine hydrochloride TABLET;ORAL 017407-003 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
QuintilesIMS
Fuji
Chinese Patent Office
Deloitte
Julphar
Daiichi Sankyo
Merck
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot